期刊文献+

丙戊酸钠对大鼠碳酸锂血清水平的影响 被引量:5

Study of effects of sodium valproate on serum lithium levels in rats
下载PDF
导出
摘要 目的探讨丙戊酸钠对碳酸锂血清水平的影响。方法20只大鼠,♀♂各半,随机分成2组,每组各10只。研究组灌喂碳酸锂15 mg.d-15 d后,于d 6开始灌喂丙戊酸钠10 mg.d-1,2种药物共同灌喂3 wk;对照组仅喂碳酸锂15 mg.d-1。分别于d 5、12、19、26抽取尾血2 mL,用于测定碳酸锂血清水平。结果2组4次的碳酸锂血清水平分别是:研究组,(0.198±0.051)(、0.215±0.062)(、0.137±0.042)(、0.177±0.122)mmol.L-1,F=1.949,P=0.139;组内差异无显著性。对照组,(0.172±0.057)(、0.185±0.054)(、0.186±0.059)(、0.180±0.029)mmol.L-1,F=0.166,P=0.919;组内差异无显著性。研究组与对照组血清锂水平比较,仅第3次差异有统计学意义(P<0.05)。结论动物实验表明,丙戊酸钠对碳酸锂的血清水平几乎没有影响,不会引起碳酸锂水平的增高。 AIM To investigate the effect of sodium valproate on serum lithium level. METHODS Twenty rats were randomly divided into study group and control group. The rats in 2 groups were bred with 15 mg lithium carbonate every day for 26 d and the rats in study group were also bred with 10 mg sodium valproate every day from d 6 after using lithium carbonate until the ending of study. The tail blood was collected d 5,12,19,26 for determining serum lithium level. RESULTS The 4 time points serum lithium levels of rats in study group were(0.198±0.051),(0.215±0.062), (0.137±0.042), (0. 177±0.122) mmol·L^-1, (F = 1.949, P = 0.139) respectively; and 4 time points serum lithium levels of rats in control group were(0. 172±0.057), (0. 185±0. 054), (0. 186±0.059), (0.180±0.029) mmol·L^-1, (F = 0. 166, P = 0.919) respectively.The differences in serum lithium level between 2 groups were not significant except difference of third serum lithium level ( P 〈 0.05). CONCLUSION Animal study indicates that sodium valproate don' t influence levels of serum lithium and don' t raise level of lithium carbonate in serum.
出处 《中国临床药学杂志》 CAS 2007年第2期116-118,共3页 Chinese Journal of Clinical Pharmacy
关键词 碳酸锂 丙戊酸钠 血清锂水平 大鼠 lithium carbonate sodium valproate serum lithium level
  • 相关文献

参考文献8

  • 1Baure MS,Mitehner L.What is a"mood stabilize"?An evidence-based response[J].Am J Psychiatry,2004,161(1):3.
  • 2Grannenman GR,Schneck DW,Cavanaugh JH,et al.Pharmacokinetic interactions and side effects resulting from concomitant administration of lithium and divaproex sodium[J].J Clin Psychiatry,1996,57(5):204.
  • 3金卫东.双相障碍的药物治疗方案与流程[J].国外医学(精神病学分册),2005,32(2):69-73. 被引量:31
  • 4卢伟明,金卫东,王鹤秋.双重心境稳定剂治疗双相障碍3例报告[J].神经疾病与精神卫生,2004,4(6):492-492. 被引量:3
  • 5McFarland BH,Miller MR,Straumfijord AA.Valproate use in the older manic patient[J].J Cliu Psychiatry,1990,51(11):479.
  • 6Goodwin FK,Jamison KP.Manic Depressive Illness[M].New York,NY:Oxford University Press,1990:675.
  • 7Reidchies FM,Hartiainen J,Berghofer AM.Initial therapy of acute mania,adding lithium and valproate to neuroleptics[J].Pharmacopsychiatry,2002,35(6):244.
  • 8Solomaon DA,Keitner GI,Ryan CE,et al.Lithium plus valproate as maintenance polypharmacy for patients with bipolar Ⅰ disorder:A review[J].J Clin Psychopharmacol,1998,18(1):38.

二级参考文献6

  • 1[1]Suppes T,Bennehy EB,Swann AC,et al. Report of Texas Consensus Conference Panel on Medication Treatment of Bipolar Disorder, 2000[J]. J Clin Psychiatry, 2002,63: 288.
  • 2[3]Goodwin FK. Rationale for using Lithium in combination with oether mood stabilizers in the management of bipolar disorder[J]. J Clin Psychinarty,2003 ,64(Sup): 18.
  • 3Suppes T, Bennehy EB, Swann AC, et al. Report of Texas Consensus Conferenee Panel on Medication Treatment of Bipolar Disorder 2000, J Clin Psychiatry, 2002, 63: 288.
  • 4Thase ME, Adeh GS. Bipolar depression: pharmaeotherapy and related therapeutic strategies. Biol Psychiatry,2000,48 (6): 558-72.
  • 5金卫东,苏宗荣,李宁,汪卫华.托吡脂联合其它抗精神病药物治疗躁狂症的初步临床观察[J].四川精神卫生,2001,14(4):196-197. 被引量:1
  • 6沈其杰,刘铁榜.双相情感障碍药物治疗规范化程序草案[J].临床精神医学杂志,2002,12(1):51-53. 被引量:20

共引文献30

同被引文献25

  • 1金卫东.双相障碍的药物治疗方案与流程[J].国外医学(精神病学分册),2005,32(2):69-73. 被引量:31
  • 2金卫东,陈炯,唐贤祥,陈震,张江涛,王鹤秋,童振华.2种心境稳定剂可以合用吗?——中国部分精神科专家意见调查[J].临床精神医学杂志,2007,17(1):63-64. 被引量:5
  • 3金卫东,陈震,陈炯.碳酸锂与丙戊酸钠联合应用的药理和临床研究进展[J].中华精神科杂志,2007,40(2):120-122. 被引量:19
  • 4Fenn HH, Robinson D, Luby V,et al. Trends in pharmacotherapy of schizoaffective and bipolar affective disorders : a 5-year naturalitic study[ J ]. Am J Psychiatry, 1996,153:711-713.
  • 5Goodwin FK. Rationale for using lithium in combination with other mood stabilizers in the management of bipolar disorder[ J]. J Clin Psychiatry,2003,64 : 18 -24.
  • 6Bowden CL.Making optimal use of combination pharmacotherapy in bipolar disorder.Clin Psychiatry,2004,65(15):21-24.
  • 7Gray NA, Zhou R, Du J, et al. The use of mood stabilizers as plasticity enhancers in the treatment of neuropsychiatric disorders. J Clin Psychiatry, 2003, 64 Suppl 5:3-7.
  • 8Goldberg JF, Citrome L. Latest therapies for bipolar disorder: looking beyond lithium. Postgrad Med, 2005, 117:25-36.
  • 9Goodwin FK. Rationale for using lithium in combination with other mood stabilizers in the management of bipolar disorder. J Clin Psychiatry, 2003, 64 Suppl 5:18-24.
  • 10Granneman GR, Schneck DW, Cavanaugh JH, et al. Pharmacokinetic interactions and side effects resulting from concomitant administration of lithium and divalproex sodium. J Clin Psychiatry, 1996, 57:204-206.

引证文献5

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部